Evidence map›Paper›PMID 36297590›Full record

ArticlePharmaceutics2022

Development of Plant Protein Derived Tri Angular Shaped Nano Zinc Oxide Particles with Inherent Antibacterial and Neurotoxicity Properties.

Tianyu Hou, Siva Sankar Sana, Huizhen Li, Xin Wang, Qinqin Wang, Vijaya Kumar Naidu Boya, Ramakrishna Vadde, Raj Kumar, Divya Vishambhar Kumbhakar, Zhijun Zhang and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Tianyu HouSchool of Chemical Engineering and Technology, North University of China, Taiyuan 030051, China.
Siva Sankar SanaSchool of Chemical Engineering and Technology, North University of China, Taiyuan 030051, China.
Huizhen LiSchool of Chemical Engineering and Technology, North University of China, Taiyuan 030051, China.
Xin WangSchool of Chemical Engineering and Technology, North University of China, Taiyuan 030051, China.
Qinqin WangSchool of Chemical Engineering and Technology, North University of China, Taiyuan 030051, China.
Vijaya Kumar Naidu BoyaDepartment of Material Science and Nanotechnology, Yogi Vemana University, Kadapa 516005, India.
Ramakrishna VaddeDepartment of Biotechnology and Bioinformatics, Yogi Vemana University, Kadapa 516005, India.
Raj KumarDepartment of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68105, USA.ORCID 0000-0002-5497-9678
Divya Vishambhar KumbhakarSchool of Medical Sciences, University of Hyderabad, Hyderabad 500046, India.ORCID 0000-0002-2388-2582
Zhijun ZhangSchool of Chemical Engineering and Technology, North University of China, Taiyuan 030051, China.
Narsimha MamidiDepartment of Chemistry and Nanotechnology, School of Engineering and Science, Tecnologico de Monterrey, Monterrey 64849, Mexico.ORCID 0000-0001-8842-4649
North University of China · CNYogi Vemana University · INTecnológico de Monterrey · MXUniversity of Hyderabad · INUniversity of Nebraska Medical Center · US

Funding

The Shanxi Scholarship Council of China HGKY2019075
6 · The paper itself

Abstract

The synthesis of nanometer-sized metallic nanoparticles utilizing bio-sources is one of the most cost-effective and ecologically friendly approaches. Nano-zinc oxide particles (N-ZnO Ps) were made using a simple green synthesis method using an aqueous zinc nitrate salt and

Indexed as

antibacterial activityanticancer activitybiosynthesisHR-TEMN-ZnO Ps

Identifiers

PMID36297590
PMCPMC9610397
OpenAlexW4304166105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.